雲南白藥(000538.SZ):中藥研發總監朱兆雲當選中國工程院院士
格隆匯11月18日丨雲南白藥(000538.SZ)宣佈,2021年11月18日,公司從中國工程院網站獲悉,中國工程院2021年院士增選結果已公佈,公司中藥研發總監朱兆雲女士當選中國工程院院士(醫藥衞生學部)。中國工程院院士是我國設立的工程科學技術方面的最高學術稱號,該院評選院士旨在鼓勵在工程科學技術方面做出重大的、創造性的成就和貢獻的個人。
朱兆雲女士長期專注於低緯高原地區中藥、民族藥和天然藥物的研發,為雲南省中醫藥、民族醫藥的發展做出了功勛卓著的貢獻,曾榮獲2012年度國家科技進步獎一等獎,2011年度雲南省科技進步獎特等獎,2014年中華中醫藥學會“中醫藥學術發展特別貢獻獎”,2015年何梁何利基金“科學與技術創新獎”、雲南省科學技術獎傑出貢獻獎等榮譽,曾獲評全國勞動模範,獲首屆全國創新爭先獎,享受國務院特殊津貼。
此次當選中國工程院院士不僅是對朱兆雲女士在我國中醫藥、民族醫藥事業所做貢獻的褒獎與肯定,還將對國家、地方以及公司未來中醫藥產業戰略的發展產生積極的推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.